Advances in bioinformatics
and genomic data analysis have enabled the identification of cancer antigens
that are generally overlooked during immune surveillance; these neoantigens
have been shown to possess substantial therapeutic potential
London
Roots Analysis is pleased to
announce the publication of its recent study, titled, “Neoantigen Targeted Therapies, 2019-2030.”
The
report features an extensive study of the current market landscape, offering an
informed opinion on the likely adoption of these therapeutics over the next
decade. It features an in-depth analysis, highlighting the capabilities of
various stakeholders engaged in this domain. In addition to other elements, the
study includes:
§ A detailed assessment of the current market landscape of developers
engaged in the development of neoantigen targeted therapies.
§ Detailed profiles of developers of neoantigen targeted
therapies (shortlisted on the basis of the number of pipeline products).
§ A detailed publication analysis of close to 300
peer-reviewed, scientific articles published during the period 2015-2019 (till
February), highlighting the research focus within the industry.
§ An in-depth analysis of the various patents that have been
filed / granted related to neoantigens.
§ An analysis of the various partnerships pertaining to
neoantigen targeting therapies.
§ An analysis of the investments made at various stages of
development in companies that are focused on developing neoantigen targeted
therapies.
§ A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
- Target Disease Indication
§
§
§
§
§
§
§
§
- Type of Treatment
§
§
- Type of Immunotherapy
§
§
§
§
- Route of Administration
§
§
§
§
- Key Geographical Region
§
§
§
§
Press
Release: Variation 1 (Format 2)
- Gabriel Nistor, Chief Scientific Officer, AIVITA
Biomedical
- Ella Sorani, Vice President Research and Development,
BioLineRx
- Heinz Lubenau, Chief Operating Officer and Co-Founder,
VAXIMM
Key companies covered in the report
§
§
§
§
§
§
§
§
§
§
For more information please click on the following link:
Other Recent
Offerings
1. T-Cell Immunotherapies Market (4th
Edition), 2019-2030
2. Novel Immuno-Oncology Biomarker
Testing Market, 2019-2030
3. Companion Diagnostics Market (2nd
Edition), 2019-2030
About Roots Analysis
Roots Analysis is one
of the fastest growing market research companies, sharing fresh and independent
perspectives in the bio-pharmaceutical industry. The in-depth research,
analysis and insights are driven by an experienced leadership team which has
gained many years of significant experience in this sector. If you’d like help
with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private
Limited
Gaurav Chaudhary
+1 (415) 800 3415
